ADHD medications and cardiovascular adverse events in children and adolescents: cross-national comparison of risk communication in drug labeling

Keyphrases

• Healthcare Professionals 100%
• Cross-national Comparison 100%
• Risk Communication 100%
• Attention Deficit Hyperactivity Disorder Medication 100%
• Medication Adverse Events 100%
• Cardiovascular Adverse Events 100%
• Drug Labeling 100%
• Adverse Events 75%
• Health Consumer 75%
• Causal Relationship 50%
• Cardiovascular Risk 50%
• Product Labeling 50%
• Myocardial Infarction 25%
• Heart Rate 25%
• Canada 25%
• Stimulant Use 25%
• Australia 25%
• Sudden Death 25%
• Elevated Blood Pressure 25%
• Medical Information 25%
• Medication Events 25%
• Cardiovascular Risk Profile 25%
• Professional Product 25%
• Drug Risk 25%
• Consumer Products 25%

Nursing and Health Professions

• Adverse Event 100%
• Attention Deficit Disorder 100%
• Adolescent 100%
• Drug Labeling 100%
• Cardiovascular Risk 75%
• Health Care Personnel 25%
• Elevated Blood Pressure 25%
• Central Stimulant Agent 25%
• Heart Infarction 25%
• Sudden Death 25%
• Cerebrovascular Accident 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Adverse Event 100%
• Attention Deficit Disorder 100%
• Risk Communication 100%
• Drug Labeling 100%
• Cardiovascular Risk 75%
• Heart Infarction 25%
• Elevated Blood Pressure 25%
• Sudden Death 25%
• Cerebrovascular Accident 25%